Brief: Nasdaq Notifies Enochian Biosciences That It Would Grant Co To Regain Compliance With Listing Rule
Dec 30 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES INC-ON DEC 27, 2022, NASDAQ NOTIFIED
CO IT
HAD DETERMINED TO GRANT EXCEPTION TO ENABLE CO TO REGAIN
COMPLIANCE WITH LISTING RULE
* ENOCHIAN BIOSCIENCES-PURSUANT TO EXCEPTION, CO MUST FILE
WITH
SEC ON OR BEFORE APRIL 11, 2023, ITS ANNUAL REPORT ON FORM 10-K,
OTHER REQUIRED FILINGS
Source: (https://bit.ly/3ju9J3Z)
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing